Dataset: Hypothesis: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging - PathMap Experiment #000100

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=100 Artificial General Intelligence LLC Claim Evaluated: Hypothesis: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights Erythroblasts in the bone marrow act as a key regulatory niche by generating specialized pro-resolving mediators (SPMs) that instruct neutrophil development and prevent premature senescent-like functional shifts. The accumulation of senescent cells, such as vascular smooth muscle cells (VSMCs), generates a senescence-associated secretory phenotype (SASP) that creates a "don't-eat-me" environment, directly disrupting macrophage efferocytosis in atherosclerosis. The "charge-sensitive" recognition mechanism, modulated by pH and cationic molecules, reveals that the microenvironment itself acts as a regulatory checkpoint for neutrophil clearance, independent of classical receptor-ligand interactions. NETs (Neutrophil Extracellular Traps) not only promote inflammation but also actively inhibit efferocytosis by cleaving macrophage surface integrins like αvβ3 and αvβ5, creating a feedback loop of persistent cellular debris. The metabolic state of the macrophage, particularly mitochondrial health and ROS-sensing pathways (e.g., DRP1 sulfenylation, AMPK phosphorylation), is an intrinsic requirement for the successful resolution of neutrophil-driven injury. Commensal-derived metabolites, such as indole-3-acetaldehyde, provide a microbiome-host axis that enhances macrophage phagocytosis via PXR/NRF2 signaling, suggesting that the lung microbiome is a modulator of efferocytic efficiency. The failure of "resolution programs" in disease is more significant than the failure of "anti-inflammatory" pathways, as evidenced by the failure of traditional anti-inflammatory drugs in clinical settings. Small-molecule TKIs, like neratinib, possess previously unrecognized pro-resolving properties, offering a repurposing opportunity to restore MerTK-mediated efferocytosis in multimorbid patients. The transition from monocyte to tissue-resident macrophage requires the enzyme deoxyhypusine synthase (DHPS). Cardiac resident macrophages rely on Maresin 1 (MaR1) signaling, which binds to PPARγ to induce CD204 expression, an efferocytosis-related target. The pentose phosphate pathway (PPP) is preferentially activated in resident thymic macrophages to manage the reduction-oxidation stress associated with efferocytosis. Systemic iron homeostasis and complement regulation, influenced by Tregs in the brain, also utilize efferocytosis-related receptors like MERTK and AXL. Microbiome modulation, including probiotics like *L. plantarum* and *L. reuteri*, can alter tryptophan metabolism (e.g., indole derivatives) to promote an anti-inflammatory state. The "interferon gap" in the elderly can be mitigated by mucosal Th1-Trm activation, proving that the mucosal immune reservoir is highly dynamic. Nano-bio interfaces, such as PET nanoplastic protein coronas, can pathologically rewire macrophage efferocytosis to facilitate tumor immune evasion. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Assess if pharmacological targeting of the charge-sensitive recognition mechanism (using cationic modulators) enhances neutrophil clearance in an aged mouse model. Determine if systemic administration of resolvin D5 (n-3 DPA) derived from erythroblasts can rejuvenate the peripheral macrophage efferocytic phenotype in aged organisms. Evaluate if inhibiting NETs using DNase I in aged models restores the CD36/MerTK signaling axis in tissue-resident macrophages. Assess if aerosolized IAAld treatment in aged mice reduces serum markers of systemic inflammation. Evaluate the impact of FMT from young to aged mice on alveolar macrophage efferocytic gene expression profiles. Measure systemic insulin sensitivity following targeted pulmonary AM efferocytosis restoration in diabetic murine models. 📊 Suggested Studies Longitudinal analysis of human patient cohorts to correlate systemic efferocytosis efficiency with biological markers of aging (e.g., epigenetic clocks). Cross-species study on the evolution of efferocytosis efficiency relative to longevity across long-lived and short-lived mammals. Investigation of the gut-lung axis in regulating efferocytosis via microbial metabolites in age-related respiratory declines. Longitudinal cohort analysis of respiratory commensal metabolites in healthy vs. accelerated aging populations. Spatial transcriptomics investigation of pulmonary macrophages in age-related frailty, focused on efferocytic receptor density. Meta-analysis of microbiome-targeted therapies and their impact on systemic inflammatory biomarkers (CRP/IL-6) in patients. 📊 Swansons Literature Based Discovery Candidates Enhancement of erythroblast-derived Resolvin D5 (RvD5n-3 DPA) signaling may ameliorate age-associated cognitive decline by normalizing the microglia-driven efferocytic resolution program. Erythroblast-derived Resolvin D5 (RvD5n-3 DPA) imprints neutrophil development and function (ID: 42519831). Reducing TRM EP2 signaling (which coordinates TRM function) limits cognitive decline in aged mice (ID: 42462036). Microglia/Brain-resident macrophages as the common cell type (specialized tissue-resident macrophages). Since erythroblasts imprint systemic granulopoiesis and tissue-resident macrophage status, and tissue-resident macrophages in the brain coordinate cognitive decline, increasing local pro-resolving lipid mediator signaling (like RvD5) may modulate the resident immune cell niche in the brain, thereby mimicking the cognitive-sparing effects of EP2 signaling inhibition. Indole-3-acetaldehyde (IAAld) acts as a potential therapeutic agent for age-related cardiac remodeling by modulating the cardiac resident macrophage (CRM) efferocytosis axis. IAAld as a metabolite of R. mucilaginosa enhances AM phagocytosis via PXR/NRF2 (ID 41715099). CRM efferocytosis promotes myocardial I/R resolution and reduces fibrosis (ID 41554295). PPAR-γ and NRF2 pathway integration in macrophage metabolism and inflammatory resolution. Both NRF2 and PPAR-γ converge on metabolic reprogramming of macrophages to improve efferocytic efficiency; IAAld-mediated activation of the PXR/NRF2 axis in AMs may be applicable to CRMs to mitigate age-related myocardial fibrosis. 📊 Contradictions Between Evidences While most evidence points to increased inflammation and impaired efferocytosis in aging, ID: 18467696 notes that adult mice show an early and acute 'cytokine storm' that is more lethal than in young mice, while ID: 18387441 reports suppressed inflammation and delayed granulation tissue in senescent hearts following injury. This suggests a context-dependent resolution dysfunction rather than simple 'inflamm-aging'. None identified in the current set; all sources consistently link macrophage efferocytic dysfunction to pathology. 📊 Repurposed Solutions Neratinib (an ErbB tyrosine kinase inhibitor) can be repurposed as an immunoresolvent to restore MerTK expression and efferocytosis in chronic inflammatory diseases (ID: 41857730). Additionally, Fucoidan can be utilized to activate the Gas6/MerTK pathway to reduce neuroinflammation (ID: 41351868). Probiotics/postbiotics designed for gut-lung axis modulation (like L. lactis or Mn-CDs) could be repurposed for cardiac or hepatic repair by leveraging common efferocytic pathways. 📊 Lung Microbiome Axis IAAld enhances RAMs/AMs phagocytosis, effectively clearing apoptotic neutrophils and LPS, which is crucial in aged tissues where efferocytic gene signatures are downregulated. 📊 Systemic Crosstalk Restoration of TRM efferocytosis prevents the release of paracrine stress signals from the lung/liver, thereby dampening systemic inflammation and distal tissue damage in aged subjects. 📊 Metabolic Checkpoint Yes, IAAld-mediated NRF2 nuclear translocation upregulates CD36, providing a metabolic checkpoint to restore phagocytic potential and mitochondrial fitness lost during aging. Tags Attractor Table Extracted Keywords & Entities Aging, _gates_from_aging, Phagocytosis, _gates_to_phagocytosis, _gates_from_phagocytosis, Neutrophils, _gates_to_neutrophils, _gates_from_neutrophils, _gates_to_aging, Indoleacetic Acids, _gates_from_indoleacetic_acids, Pregnane X Receptor, _gates_to_pregnane_x_receptor, NF-E2-Related Factor 2, _gates_from_nf-e2-related_factor_2, Macrophages, Alveolar, _gates_to_macrophages,_alveolar, _gates_from_macrophages,_alveolar, Inflammation, _gates_to_inflammation Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.